Mr. Ben Ami holds a Master of Health Systems Administration degree (M.H.A.) from Tel Aviv University, Israel.
Mr. Doron Ben Ami has been Therapix’s Chief Strategy Officer since December 2015. A seasoned executive with more than 20 years of management experience, he has held various leadership roles in the multinational pharmaceutical industry.